Related Experiment Video
Updated: Oct 10, 2025

Preparation of Acute Brain Slices Using an Optimized N-Methyl-D-glucamine Protective Recovery Method
Published on: February 26, 2018
The Orexin System: A Potential Player in the Pathophysiology of Absence Epilepsy
Roberta Celli1, Gilles Van Luijtelaar2
1I.R.C.C.S. Neuromed, Pozzilli, Italy.
Background:
Absence epilepsy is characterized by the presence of spike-and-wave discharges (SWDs) at the EEG generated within the cortico-thalamo-cortical circuit. The molecular mechanisms involved in the pathophysiology of absence epilepsy are only partially known. WAG/Rij rats older than 2-3 months develop spontaneous SWDs, and they are sensitive to anti- absence medications. Hence, WAG/Rij rats are extensively used as a model for absence epilepsy with predictive validity.
Objective:
The aim of the study was to examine the possibility that the orexin system, which supports the wake status in experimental animals and humans, plays a role in the pathophysiology of absence seizures.
Methods:
The perspective grounds its method from recent literature along with measurements of orexin receptor type-1 (OX1) protein levels in the thalamus and somatosensory cortex of WAG/Rij rats and non-epileptic Wistar control rats at two ages (25 days and 6-7 months). OX1 protein levels were measured by immunoblotting.
Results:
The analysis of the current literature suggests that the orexin system might be involved in the pathophysiology of absence epilepsy and might be targeted by therapeutic intervention. Experimental data are in line with this hypothesis, showing that OX1 protein levels were reduced in the thalamus and somatosensory cortex of symptomatic WAG/Rij rats (6-7 months of age) with respect to non-epileptic controls, whereas these differences were not seen in pre-symptomatic, 25 days-old WAG/Rij rats.
Conclusion:
This perspective might pave the way for future studies on the involvement of the orexinergic system in the pathophysiology of SWDs associated with absence epilepsy and its comorbidities.
Insights
Researchers investigated the orexin system
Area of Science:
- Neuroscience
- Epilepsy Research
- Molecular Biology
Background:
- Absence epilepsy is characterized by spike-and-wave discharges (SWDs) within the cortico-thalamo-cortical circuit.
- The precise molecular mechanisms underlying absence epilepsy pathophysiology remain incompletely understood.
- Wistar Albino Glaxo/Rij (WAG/Rij) rats serve as a validated animal model for absence epilepsy, exhibiting spontaneous SWDs.
Purpose of the Study:
- To investigate the potential role of the orexin system in the pathophysiology of absence seizures.
- To explore the orexin system as a potential therapeutic target for absence epilepsy.
Main Methods:
- Orexin receptor type-1 (OX1) protein levels were quantified in the thalamus and somatosensory cortex of WAG/Rij rats and control Wistar rats.
- Protein levels were assessed at two developmental stages: pre-symptomatic (25 days) and symptomatic (6-7 months).
- Immunoblotting was employed to measure OX1 protein levels.
Main Results:
- Reduced OX1 protein levels were observed in the thalamus and somatosensory cortex of symptomatic WAG/Rij rats compared to non-epileptic controls.
- No significant differences in OX1 protein levels were found between pre-symptomatic WAG/Rij rats and controls.
- These findings suggest a potential link between orexin system dysfunction and the development of absence epilepsy.
Conclusions:
- The orexin system may be implicated in the pathophysiology of SWDs associated with absence epilepsy.
- This research opens avenues for future investigations into the orexinergic system's role in absence epilepsy and its comorbidities.
- Targeting the orexin system could represent a novel therapeutic strategy for absence epilepsy.
More Related Videos
06:23A Chronic Sleep Fragmentation Model using Vibrating Orbital Rotor to Induce Cognitive Deficit and Anxiety-Like Behavior in Young Wild-Type Mice
Published on: September 22, 2020
09:32Network Analysis of Foramen Ovale Electrode Recordings in Drug-resistant Temporal Lobe Epilepsy Patients
Published on: December 18, 2016
Related Concept Videos
Sleep-Wake Cycles
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
Neurotransmitters
Narcolepsy
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...